Search Results - "Fulforth, J"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    P127 Inflammatory Bowel Disease-associated colorectal cancers: retrospective cohort study from a tertiary centre surveillance programme over 10 years by Porter, R, Gillespie, S L, Song, M, Ball, G, Crawford, A, Churchhouse, A, Gardner, M, Plevris, N, Chuah, C S, Brindle, W, Watson, E, Jenkinson, P, Fulforth, J, Kedziora, M, Dickson, B, Megan, A, Jones, G R, Din, S

    Published in Journal of Crohn's and colitis (30-01-2023)
    “…Abstract Background Patients with IBD have increased risk for developing colorectal cancer (CRC), with poorer survival, compared to those without IBD. Despite…”
    Get full text
    Journal Article
  2. 2

    DOP11 Normalisation of faecal calprotectin within 12 months of diagnosis is associated with a reduced risk of disease progression in Crohn’s disease by Plevris, N, Fulforth, J, Jenkinson, P, Lyons, M, Chuah, C, Siakavellas, S, Pattenden, R, Arnott, I, Jones, G, Lees, C

    Published in Journal of Crohn's and colitis (15-01-2020)
    “…Abstract Background Faecal calprotectin (FC) demonstrates an excellent correlation with endoscopic inflammation. In addition, a treatment-decision algorithm…”
    Get full text
    Journal Article
  3. 3

    DOP87 Multi-parameter datasets are required to identify the true prevalence of IBD: The Lothian IBD Registry (LIBDR) by Jones, G-R, Lyons, M, Plevris, N, Jenkinson, P, Bisset, C, Fulforth, J, Chuah, C S, Minnis, S, Gillespie, S-L, Brindle, W, Burgess, C, Henderson, P, Wilson, D, Lees, C

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background A recent systematic review reports stabilising or falling IBD incidence in Western countries with an overall prevalence in excess of 0.3%.1…”
    Get full text
    Journal Article
  4. 4